Kuromatsuen; Kuromatsuene; Longifolen; Longifolene; Junipen; Junipene; D-Longifolene; (+)-Longifolen; (1S,3Ar,4S,8As)-4,8,8-Trimethyl-9-Methylenedecahydro-1,4-Methanoazulene; [1S-(1Alpha,3Abeta,4Alpha,8Abeta)]-Decahydro-4,8,8-Trimethyl-9-Methylene-1,4-Methanoazulene; (1S,3Ar,4S,8As)-4,8,8-Trimethyl-9-Methylidenedecahydro-1,4-Methanoazulene; (1S,3Ar,4S,8As)-(+)-Decahydro-4,8,8-Trimethyl-9-Methylene-1,4-Methanoazulene; 1,4-Methanoazulene, Decahydro-4,8,8-Trimethyl-9-Methylene-

Brief Introduction

(+)-Longifolene is a natural flavor extracted from heavy turpentine. It has special chemical activity. It is a raw material for synthetic resin, synthetic flavor, flotation agent and organic synthesis.

2,6-Dimethoxypyrazine

MSDS

CAS:4774-15-6

Molecular Formula:C6H8N2O2

Brief Introduction

This product is used as a pharmaceutical intermediate.

4-Bromocinnamaldehyde

MSDS

CAS:49678-04-8

Molecular Formula:C9H7BrO

Alias

More Information

Trans-3-(4-Bromophenyl)-2-Propenal; 3-(4-Bromophenyl)Acrylaldehyde; Trans-3-(4-Bromophenyl)Acrolein; Trans-3-(4-Bromophenyl)Acrylaldehyde; 2-Propenal, 3-(4-Bromophenyl)-,(2E); Trans-4-Bromocinnamaldehyde; (E)-3-(4-Bromophenyl)Propenal; (E)-4-Bromocinnamaldehyde; 4-Bromo-Trans-Cinnamaldehyde

Brief Introduction

This product is organic and can be used for organic synthesis.

Rimexolone

MSDS

CAS:49697-38-3

Molecular Formula:C24H34O3

Alias

More Information

(8S,9S,10R,11S,13S,14S,16R,17S)-11-Hydroxy-10,13,16,17-Tetramethyl-17-Propionyl-6,7,8,9,10,11,12,13,14,15,16,17-Dodecahydro-3H-Cyclopenta[A]Phenanthren-3-One; Asoprisnil Ecamate; Vexol; Org-6216

Brief Introduction

Rimexolone is a derivative of prednisolone, a synthetic glucocorticoid with anti-inflammatory and immunosuppressive property. Upon binding to the cytosolic glucocorticoid receptor and cell entry, rimexolone activates specific glucocorticoid response elements, resulting in altered gene expression. These include induction of synthesis of anti-inflammatory protein IkappaB-alpha and inhibition of synthesis of nuclear factor kappaB (NFkappa B). As a result, pro-inflammatory cytokine production such as interleukin-1 (IL-1), IL-2 and IL-6 is down-regulated and cytotoxic T-lymphocyte activation inhibited. Therefore, an overall reduction in chronic inflammation and autoimmune reactions may be achieved.

Inquiry (

/ 10

)

Clear All